Skip to main content
. 2000 Jan;15(1):56–67. doi: 10.1046/j.1525-1497.2000.04329.x

FIGURE 2.

FIGURE 2

FIGURE 2

FIGURE 2

(a)Trials of warfarin versus placebo for patients with atrial fibrillation; odds ratios for stroke and hemorrhage. 1CAFA indicates Canadian Atrial Fibrillation Anticoagulation study: EAFT, European Atrial Fibrillation Trial; SPAF, Stroke Prevention in Atrial Fibrillation; SPINAF, Stroke Prevention in Nonrheumatic Atrial Fibrillation; BAATAF, Boston Area Anticoagulation Trial in Atrial Fibrillation. *Horizontal bars represent 95% confidence intervals surrounding the point estimates of the odds ratios. (b).Trials of aspirin versus placebo for patients with atrial fibrillation; odds ratios for stroke and hemorrhage. Abbreviations and symbols are explained in the legend to Figure 2a. (c).Trials of warfarin versus aspirin for patients with atrial fibrillation; odds ratios for stroke and hemorrhage. Abbreviations and symbols are explained in the legend to Figure 2a.